Navigating US Market Access During COVID-19
US life sciences market access has become one of the biggest challenges created by the COVID-19 pandemic. Travel restrictions and lockdowns have limited in-person engagement, forcing companies to rethink how they connect with customers, partners, and decision-makers in the US market.
The United States remains the largest life sciences market in the world. However, travel restrictions have made physical access impossible for many companies. As a result, pipeline development and customer engagement have slowed.
The Loss of Traditional Market Engagement
In normal conditions, US market entry includes frequent conference attendance and roadshows. Companies also rely on in-person meetings to build trust and expand relationships. These activities typically drive steady CRM growth.
Today, those methods are unavailable. Without face-to-face interaction, many organizations struggle to generate qualified leads. Maintaining momentum has become more difficult.
Why Local Presence Still Matters
“Boots on the ground” has always mattered in the US market. Local knowledge builds credibility and trust. Familiar accents, regional insight, and cultural awareness often open doors faster.
This advantage has historically helped British and Irish companies succeed in the US. COVID-19 removed that option. However, the need for local expertise did not disappear.
The Role of Global Life Sciences Alliance (GLSA)
Global Life Sciences Alliance (GLSA) was built to solve this problem. GLSA connects companies with experienced US-based business development professionals. These professionals bring deep expertise across drug discovery and development.
With more than 40,000 industry relationships, GLSA extends your reach immediately. Most alliance members live and work in the US. Their existing networks create access that would otherwise take years to build.
A Relationship-Driven Approach to Growth
GLSA does not use generic outreach or blanket sales messaging. Instead, we focus on relationships. Our team understands the real needs of pharma companies, biotechs, and CROs.
This insight allows us to position solutions with context and relevance. Conversations start with problems, not pitches. As a result, engagement is stronger and outcomes improve.
Strategic Insight Beyond Sales
GLSA offers more than market access. Our partners have built and scaled their own companies. They understand growth, risk, and commercial execution.
This experience allows us to contribute strategically. We help refine positioning and adapt go-to-market approaches. Clients benefit from objective insight and practical guidance.
A Cost-Effective Alternative to US Expansion
Hiring a full-time US business development professional is expensive. Recruitment, salary, and ongoing costs add up quickly. For many companies, this investment is not practical.
GLSA offers a flexible alternative. Clients gain access to multiple professionals and perspectives at a lower cost. This model delivers speed, scale, and efficiency.
Staying Visible When Travel Isn’t Possible
GLSA uses targeted outreach and digital engagement to keep clients visible. We leverage relationships, marketing, and messaging to maintain momentum. Physical distance no longer prevents meaningful market presence.
If crossing the Atlantic is not an option, growth is still achievable.
Let’s Open the Door Together
GLSA helps life sciences companies access the US market during uncertain times. We combine local expertise, trusted relationships, and strategic thinking.
Reach out to explore how we can support your US growth—without getting on a plane.
Dr. Robert Grundy
Partner, Global Life Sciences Alliance
About GLSA
Global Life Sciences Alliance (GLSA) connects biotechs, pharma, CROs, and clinical research sites with the right experts, advisors, and solutions to accelerate development and reduce risk. With a network of more than 200 trusted partners spanning pre-clinical and clinical research, GLSA offers flexible, cost-effective access to specialized expertise and services that support early-stage biotechs, mid-size pharma, and global pharmaceutical companies.
When you need trusted, global resources to accelerate your research, GLSA helps you scale smarter and move you forward with confidence.
To learn how GLSA can support your organization, connect with Denise McNerney or Chris Matheus for a conversation about your goals and challenges.